PsyBio Therapeutics Corp.
PSYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 153.99% | 48.81% | 58.92% | 60.27% | 62.46% |
| Total Depreciation and Amortization | -100.00% | 0.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -533.83% | -41.18% | -98.45% | -87.23% | -74.30% |
| Change in Net Operating Assets | -77.19% | 312.91% | 302.69% | 30.16% | -122.00% |
| Cash from Operations | 72.27% | 71.76% | 92.52% | 55.16% | 46.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.96% | -- | -100.00% | -50.35% | 118.42% |
| Cash from Investing | -99.96% | -- | -100.00% | -50.35% | 118.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4,588.57% | -- | -- | -- | -- |
| Cash from Financing | 549.48% | 732.17% | 178.84% | -- | -- |
| Foreign Exchange rate Adjustments | 250.00% | -600.00% | -- | -76.19% | 111.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.65% | -310.69% | 93.90% | -18.01% | 99.50% |